“Using valuation as a standalone variable can be misleading and it has to be seen in the context of earnings growth. When one juxtaposes earnings growth expectations along with current valuations, we see no reason to prune market exposure or turn cautious,” says Abhishek Gupta, fund manager – equity, at the fund house.
Wakefit IPO: Check GMP, price band, review, subscription and other details
Wakefit Innovations, known for its mattresses, is launching its IPO with a positive grey market outlook. The company is raising over Rs 1,200 crore. Despite